Market Research

North America Multiomics Market Size, Share & Industry Trends Analysis Report By Type (Bulk Multiomics, and Single-cell Multiomics), By Product & Service, By End-use, By Platform, By Application, By Country and Growth Forecast, 2023 - 2030

Best Price Guarantee Length Publisher Published Date SKU
from $1,500 156 Pages Knowledge Based Value (KBV) Research October, 2023 KBV18339150
Best Price Guarantee
Price from $1,500
Length 156 Pages
Publisher Knowledge Based Value (KBV) Research
Published Date October, 2023
SKU KBV18339150

North America Multiomics Market Size, Share & Industry Trends Analysis Report By Type (Bulk Multiomics, and Single-cell Multiomics), By Product & Service, By End-use, By Platform, By Application, By Country and Growth Forecast, 2023 - 2030


The North America Multiomics Market would witness market growth of 14.4% CAGR during the forecast period (2023-2030).

In the rapidly evolving landscape of life sciences and biomedical research, multiomics is emerging as a transformative approach with profound implications for understanding human biology, disease mechanisms, and personalized healthcare. It is a groundbreaking discipline that integrates and analyzes multiple layers of biological data at the molecular level. Combining genomics, transcriptomics, proteomics, metabolomics, and other "omics" disciplines offers a holistic view of complex biological systems, enabling comprehensive insights into health and disease.

Multiomics data integration has revolutionized cancer research by identifying critical driver mutations, unravelling tumour heterogeneity, and discovering potential biomarkers for early diagnosis and targeted therapies. It has allowed for a deeper understanding of host-pathogen interactions in infectious diseases, aiding in developing vaccines and therapeutics. Multiomics data facilitates the identification of novel drug targets, enabling the pharmaceutical industry to develop more effective and specific therapies.

Multiomics data integration allows researchers to pinpoint critical driver mutations responsible for the initiation and progression of cancer. By examining cancer cells' genomic and transcriptomic profiles, scientists can identify genetic alterations that drive oncogenesis. This knowledge is invaluable for developing targeted therapies that specifically inhibit the action of these mutations. For example, identifying specific mutations in genes like EGFR (Epidermal Growth Factor Receptor) in non-small cell lung cancer (NSCLC) has led to targeted therapies like gefitinib and erlotinib.

The healthcare sector in Canada is a major focus of biotechnology. The country is home to numerous biopharmaceutical companies involved in drug discovery, development, and manufacturing. Research institutions and universities conduct cutting-edge research in genomics, proteomics, and personalized medicine. According to the Government of Manitoba data, as the leading pharmaceutical manufacturing center in Western Canada, Manitoba is a hub for life sciences and biotechnology. Manitoba is Canada's second-largest province for pharmaceutical and medicine manufacturing, with $5.4 billion in exports (2022). Thus, the rising biotechnology sector in countries like the United States and Canada will enhance its demand in the North America region.

The US market dominated the North America Multiomics Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,871.3 million by 2030. The Canada market is experiencing a CAGR of 17% during (2023 - 2030). Additionally, The Mexico market would register a CAGR of 16% during (2023 - 2030).

Based on Type, the market is segmented into Bulk Multiomics, and Single-cell Multiomics. Based on Product & Service, the market is segmented into Product (Instruments, Consumables, and Software), and Services. Based on End-use, the market is segmented into Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others. Based on Platform, the market is segmented into Genomics, Transcriptomics, Proteomics, Metabolomics, and Integrated Omics Platforms. Based on Application, the market is segmented into Cell Biology, Oncology, Neurology, and Immunology. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc, Illumina, Inc., Danaher Corporation, PerkinElmer, Inc., Bruker Corporation, Qiagen N.V., Agilent Technologies, Inc., BGI Group, Becton, Dickinson, and Company, Shimadzu Corporation

Scope of the Study

Market Segments covered in the Report:

By Type
  • Bulk Multiomics
  • Single-cell Multiomics
By Product & Service
  • Product
  • Instruments
  • Consumables
  • Software
  • Services
By End-use
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Others
By Platform
  • Genomics
  • Transcriptomics
  • Proteomics
  • Metabolomics
  • Integrated Omics Platforms
By Application
  • Cell Biology
  • Oncology
  • Neurology
  • Immunology
By Country
  • US
  • Canada
  • Mexico
  • Rest of North America
Companies Profiled
  • Thermo Fisher Scientific, Inc
  • Illumina, Inc.
  • Danaher Corporation
  • PerkinElmer, Inc.
  • Bruker Corporation
  • Qiagen N.V.
  • Agilent Technologies, Inc.
  • BGI Group
  • Becton, Dickinson, and Company
  • Shimadzu Corporation
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Multiomics Market, by Type
1.4.2 North America Multiomics Market, by Product & Service
1.4.3 North America Multiomics Market, by End-use
1.4.4 North America Multiomics Market, by Platform
1.4.5 North America Multiomics Market, by Application
1.4.6 North America Multiomics Market, by Country
1.5 Methodology for the research
Chapter 2. Market At a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Geographical Expansions
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2021, Jun – 2023, Mar) Leading Players
4.4 Porter’s Five Force Analysis
Chapter 5. North America Multiomics Market by Type
5.1 North America Bulk Multiomics Market by Region
5.2 North America Single-cell Multiomics Market by Region
Chapter 6. North America Multiomics Market by Product & Service
6.1 North America Product Market by Country
6.2 North America Multiomics Market by Product Type
6.2.1 North America Instruments Market by Country
6.2.2 North America Consumables Market by Country
6.2.3 North America Software Market by Country
6.3 North America Services Market by Country
Chapter 7. North America Multiomics Market by End-use
7.1 North America Academic & Research Institutes Market by Country
7.2 North America Pharmaceutical & Biotechnology Companies Market by Country
7.3 North America Others Market by Country
Chapter 8. North America Multiomics Market by Platform
8.1 North America Genomics Market by Country
8.2 North America Transcriptomics Market by Country
8.3 North America Proteomics Market by Country
8.4 North America Metabolomics Market by Country
8.5 North America Integrated Omics Platforms Market by Country
Chapter 9. North America Multiomics Market by Application
9.1 North America Cell Biology Market by Country
9.2 North America Oncology Market by Country
9.3 North America Neurology Market by Country
9.4 North America Immunology Market by Country
Chapter 10. North America Multiomics Market by Country
10.1 US Multiomics Market
10.1.1 US Multiomics Market by Type
10.1.2 US Multiomics Market by Product & Service
10.1.2.1 US Multiomics Market by Product Type
10.1.3 US Multiomics Market by End-use
10.1.4 US Multiomics Market by Platform
10.1.5 US Multiomics Market by Application
10.2 Canada Multiomics Market
10.2.1 Canada Multiomics Market by Type
10.2.2 Canada Multiomics Market by Product & Service
10.2.2.1 Canada Multiomics Market by Product Type
10.2.3 Canada Multiomics Market by End-use
10.2.4 Canada Multiomics Market by Platform
10.2.5 Canada Multiomics Market by Application
10.3 Mexico Multiomics Market
10.3.1 Mexico Multiomics Market by Type
10.3.2 Mexico Multiomics Market by Product & Service
10.3.2.1 Mexico Multiomics Market by Product Type
10.3.3 Mexico Multiomics Market by End-use
10.3.4 Mexico Multiomics Market by Platform
10.3.5 Mexico Multiomics Market by Application
10.4 Rest of North America Multiomics Market
10.4.1 Rest of North America Multiomics Market by Type
10.4.2 Rest of North America Multiomics Market by Product & Service
10.4.2.1 Rest of North America Multiomics Market by Product Type
10.4.3 Rest of North America Multiomics Market by End-use
10.4.4 Rest of North America Multiomics Market by Platform
10.4.5 Rest of North America Multiomics Market by Application
Chapter 11. Company Profiles
11.1 Thermo Fisher Scientific, Inc.
11.1.1 Company Overview
11.1.2 Financial Analysis
11.1.3 Segmental and Regional Analysis
11.1.4 Research & Development Expenses
11.1.5 SWOT Analysis
11.2 Illumina, Inc.
11.2.1 Company Overview
11.2.2 Financial Analysis
11.2.3 Segmental and Regional Analysis
11.2.4 Research & Development Expense
11.2.5 Recent strategies and developments:
11.2.5.1 Partnerships, Collaborations, and Agreements:
11.2.5.2 Product Launches and Product Expansions:
11.2.5.3 Acquisition and Mergers:
11.2.5.4 Geographical Expansions:
11.2.6 SWOT Analysis
11.3 Danaher Corporation
11.3.1 Company Overview
11.3.2 Financial Analysis
11.3.3 Segmental and Regional Analysis
11.3.4 Research & Development Expense
11.3.5 SWOT Analysis
11.4 PerkinElmer, Inc.
11.4.1 Company Overview
11.4.2 Financial Analysis
11.4.3 Segmental and Regional Analysis
11.4.4 Research & Development Expense
11.4.5 SWOT Analysis
11.5 Bruker Corporation
11.5.1 Company Overview
11.5.2 Financial Analysis
11.5.3 Segmental and Regional Analysis
11.5.4 Research & Development Expense
11.5.5 Recent strategies and developments:
11.5.5.1 Partnerships, Collaborations, and Agreements:
11.5.5.2 Product Launches and Product Expansions:
11.5.5.3 Acquisition and Mergers:
11.5.6 SWOT Analysis
11.6 Qiagen N.V.
11.6.1 Company Overview
11.6.2 Financial Analysis
11.6.3 Regional Analysis
11.6.4 Research & Development Expense
11.6.5 SWOT Analysis
11.7 Agilent Technologies, Inc.
11.7.1 Company Overview
11.7.2 Financial Analysis
11.7.3 Segmental and Regional Analysis
11.7.4 Research & Development Expense
11.7.5 Recent strategies and developments:
11.7.5.1 Partnerships, Collaborations, and Agreements:
11.7.6 SWOT Analysis
11.8 BGI Group
11.8.1 Company Overview
11.8.2 Recent strategies and developments:
11.8.2.1 Partnerships, Collaborations, and Agreements:
11.8.3 SWOT Analysis
11.9 Becton, Dickinson, and Company
11.9.1 Company Overview
11.9.2 Financial Analysis
11.9.3 Segmental and Regional Analysis
11.9.4 Research & Development Expense
11.9.4.1 Product Launches and Product Expansions:
11.9.5 SWOT Analysis
11.10. Shimadzu Corporation
11.10.1 Company Overview
11.10.2 Financial Analysis
11.10.3 Segmental and Regional Analysis
11.10.4 Research & Development Expense
11.10.5 SWOT Analysis

$1,500
$1,800
$2,520

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings